List view / Grid view




TxCell reports revenues for 2014 and updates on upcoming milestones

5 February 2015 | By TxCell

TxCell, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, reports its revenues as of December 31, 2014 and updates on forthcoming milestones...